Efficacy of Off-Label Use of Anticancer Drugs in Oncology
Article in Creative Surgery and Oncology (June 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Analysis of medical malpractice liability disputes related to novel antineoplastic drugs and research on risk prevention and control strategies
Article in PLOS ONE (June 2023)
Off-label use of immune checkpoint inhibitors for the treatment of solid tumors: analysis of a nationwide patient sample
Article in Journal of Cancer Research and Clinical Oncology (April 2023)